Search research articles
Contact Us
Filters
Showing results (81-90 of 101) with videos related to
Page
of 11
Sort By:
Journal of Neuropathology and Experimental Neurology
|
November 1, 1980
Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin diabetic nerve
K Sugimura, A J Windebank, V Natarajan, et al.
Annals of the New York Academy of Sciences
|
January 1, 1987
Definition of myasthenogenic sites of the human acetylcholine receptor using synthetic peptides
V A Lennon, G A Griesmann, D J McCormick, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1997
A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis
H Yoshikawa, E H Lambert, D R Walser-Kuntz, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
Synthetic peptide of human acetylcholine receptor alpha-subunit sequence 125-147 (methionine 144), a more potent autoantigen than its norleucine 144 analog
V A Lennon, Z X Huang, D J McCormick, et al.
Annals of Neurology
|
October 1, 1979
Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis
P J Dyck, J A Carney, G W Sizemore, et al.
Journal of Neuropathology and Experimental Neurology
|
November 1, 1980
Structural and biochemical effects of essential fatty acid deficiency on peripheral nerve
B A Evans, J K Yao, R T Holman, et al.
Neurology
|
October 1, 1979
Comparison of symptoms, chemistry, and nerve function to assess adequacy of hemodialysis
P J Dyck, W J Johnson, E H Lambert, et al.
Proceedings of the Clinical Dialysis and Transplant Forum
|
November 18, 1978
Comparison of symptoms, chemistry, and nerve function to assess hemodialysis adequacy
P J Dyck, W J Johnson, E H Lambert, et al.
Muscle & Nerve
|
January 1, 1996
A transgenic mouse model of the slow-channel syndrome
C M Gomez, B B Bhattacharyya, P Charnet, et al.
Annals of the New York Academy of Sciences
|
January 1, 1981
Recently recognized congenital myasthenic syndromes: (a) end-plate acetylcholine (ACh) esterase deficiency (b) putative abnormality of the ACh induced ion channel (c) putative defect of ACh resynthesis or mobilization - clinical features, ultrastructure and cytochemistry
A G Engel, E H Lambert, D M Mulder, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 101) with videos related to
Sort By:
Page
of 11
Journal of Neuropathology and Experimental Neurology
|
November 1, 1980
Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin diabetic nerve
K Sugimura, A J Windebank, V Natarajan, et al.
Annals of the New York Academy of Sciences
|
January 1, 1987
Definition of myasthenogenic sites of the human acetylcholine receptor using synthetic peptides
V A Lennon, G A Griesmann, D J McCormick, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1997
A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis
H Yoshikawa, E H Lambert, D R Walser-Kuntz, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
Synthetic peptide of human acetylcholine receptor alpha-subunit sequence 125-147 (methionine 144), a more potent autoantigen than its norleucine 144 analog
V A Lennon, Z X Huang, D J McCormick, et al.
Annals of Neurology
|
October 1, 1979
Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis
P J Dyck, J A Carney, G W Sizemore, et al.
Journal of Neuropathology and Experimental Neurology
|
November 1, 1980
Structural and biochemical effects of essential fatty acid deficiency on peripheral nerve
B A Evans, J K Yao, R T Holman, et al.
Neurology
|
October 1, 1979
Comparison of symptoms, chemistry, and nerve function to assess adequacy of hemodialysis
P J Dyck, W J Johnson, E H Lambert, et al.
Proceedings of the Clinical Dialysis and Transplant Forum
|
November 18, 1978
Comparison of symptoms, chemistry, and nerve function to assess hemodialysis adequacy
P J Dyck, W J Johnson, E H Lambert, et al.
Muscle & Nerve
|
January 1, 1996
A transgenic mouse model of the slow-channel syndrome
C M Gomez, B B Bhattacharyya, P Charnet, et al.
Annals of the New York Academy of Sciences
|
January 1, 1981
Recently recognized congenital myasthenic syndromes: (a) end-plate acetylcholine (ACh) esterase deficiency (b) putative abnormality of the ACh induced ion channel (c) putative defect of ACh resynthesis or mobilization - clinical features, ultrastructure and cytochemistry
A G Engel, E H Lambert, D M Mulder, et al.
Page
of 11